GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES

被引：0

作者：

Deodhar, Atul ^{[1
]}

Mease, Philip J. ^{[2
,3
]}

Boencke, Wolf-Henning ^{[4
]}

Tesser, John ^{[5
]}

Schiopu, Elena ^{[6
]}

Chakravarty, Soumya D. ^{[7
,8
]}

Kollmeier, Alexa P. ^{[9
]}

Hsia, Elizabeth C. ^{[9
,10
]}

Xu, Xie L. ^{[9
]}

Shawi, May ^{[11
]}

Jiang, Yusang ^{[9
]}

Sheng, Shihong ^{[9
]}

Agarwal, Prasheen ^{[9
]}

Merola, Joseph F. ^{[12
]}

McInnes, Iain B. ^{[13
]}

Ritchlin, Christopher T. ^{[14
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Swedish Med Ctr, Providence St Joseph Hlth, Seattle, WA USA

[3] Univ Washington, Seattle, WA 98195 USA

[4] Geneva Univ Hosp, Geneva, Switzerland

[5] Arizona Arthrit & Rheumatol Associates, Phoenix, AZ USA

[6] Michigan Med Rheumatol Clin, Ann Arbor, MI USA

[7] Janssen Sci Affairs LLC, Horsham, PA USA

[8] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[9] Janssen Res & Dev LLC, Spring House, PA USA

[10] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA

[11] Janssen Global Serv LLC, Horsham, PA USA

[12] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[13] Univ Glasgow, Glasgow, Lanark, Scotland

[14] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷

关键词：

BIOLOGIC-NAIVE; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PANLAR2021

引用

页码：S108 / S109

页数：2

共 50 条

[1] Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies
Deodhar, Atul
Mease, Philip
Boehncke, Wolf-Henning
Tesser, John
Schiopu, Elena
Chakravarty, Soumya
Kollmeier, Alexa
Hsia, Elizabeth
Xu, Xie
Shawi, May
Jiang, Yusang
Sheng, Shihong
Agarwal, Prasheen
Merola, Joseph
McInnes, Iain
Ritchlin, Christopher
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[2] SUSTAINED GUSELKUMAB RESPONSE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS REGARDLESS OF BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS THROUGH WEEK 52 OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
Ritchlin, C. T.
Mease, P. J.
Boehncke, W. H.
Tesser, J.
Schiopu, E.
Chakravarty, S. D.
Kollmeier, A.
Hsia, E. C.
Xu, X. L.
Shawi, M.
Jiang, Y.
Sheng, S.
Merola, J. F.
McInnes, I.
Deodhar, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1291 - 1292
[3] Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
Ritchlin, Christopher T.
Mease, Philip J.
Boehncke, Wolf-Henning
Tesser, John
Schiopu, Elena
Chakravarty, Soumya D.
Kollmeier, Alexa P.
Xu, Xie L.
Shawi, May
Jiang, Yusang
Sheng, Shihong
Wang, Yanli
Xu, Stephen
Merola, Joseph F.
McInnes, Iain B.
Deodhar, Atul
[J]. RMD OPEN, 2022, 8 (01):
[4] IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB
Nash, P.
Mcinnes, I.
Ritchlin, C. T.
Tam, L. S.
Soriano, E.
Starr, M.
Rampakakis, E.
Lavie, F.
Shawi, M.
Baraliakos, X.
Mease, P. J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1771 - 1772
[5] Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
Felten, Renaud
Widawski, Laura
Spielman, Lionel
Gottenberg, Jacques-Eric
Duret, Pierre-Marie
Rampakakis, Emmanouil
Sharaf, Mohamed
Constantin, Caren
Campana, Vincenza
Messer, Laurent
[J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4429 - 4432
[6] Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab
Nash, Peter
McInnes, Iain
Ritchlin, Christopher T.
Tam, Lai-Shan
Soriano, Enrique
Starr, Michael
Rampakakis, Emmanouil
Lavie, Frederic
Shawi, May
Baraliakos, Xenofon
Mease, Philip J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2785 - 2787
[7] EFFICACY OF GUSELKUMAB ACROSS BASDAI COMPONENTS IN TREATING AXIAL-RELATED SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
Behrens, F.
Mease, P. J.
Helliwell, P.
Shawi, M.
Noel, W.
Chakravarty, D.
Kollmeier, A.
Xu, X. L.
Xu, S.
Wang, Y.
Baraliakos, X.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1289 - 1290
[8] Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies
Behrens, Frank
Mease, Philip
Helliwell, Philip S.
Shawi, May
Noel, Wim
Chakravarty, Soumya
Xu, Alexa Kollmeier Xie
Xu, Xie
Xu, Stephen
Wang, Yanli
Baraliakos, Xenofon
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3778 - 3780
[9] Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
Siebert, Stefan
Sweet, Kristen M.
Ritchlin, Christopher T.
Hsia, Elizabeth C.
Kollmeier, Alexa P.
Xu, Xie L.
Seridi, Loqmane
Song, Qingxuan
Gao, Sheng
Chen, Warner
Miron, Michelle
[J]. ACR OPEN RHEUMATOLOGY, 2023, 5 (09) : 490 - 498
[10] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
Rahman, P.
Ritchlin, C.
Helliwell, P.
Boehncke, W. H.
Mease, P.
Gottlieb, A. B.
Kafka, S.
Kollmeier, A.
Hsia, E.
Xu, X. L.
Shawi, M.
Sheng, S.
Zhou, B.
Ramachandran, P.
McInnes, I.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1218 - 1218

← 1 2 3 4 5 →